XML 319 R109.htm IDEA: XBRL DOCUMENT v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)
Ordinary Shares
Class A Ordinary Shares
HCM II ACQUISITION CORP
Ordinary Shares
Class B
HCM II ACQUISITION CORP
Additional Paid-in Capital
HCM II ACQUISITION CORP
Additional Paid-in Capital
Accumulated Deficit
HCM II ACQUISITION CORP
HCM II ACQUISITION CORP
Total
Beginning Balance at Apr. 03, 2024 $ 0 $ 0 $ 0   $ 0 $ 0  
Beginning Balance (in Shares) at Apr. 03, 2024 0 0          
Issuance of Class B ordinary shares to Sponsor [1] $ 575 24,425   25,000  
Number of shares issued [1]   5,750,000          
Net income   (52,663) (52,663)  
Ending Balance at Jun. 30, 2024 $ 575 24,425   (52,663) (27,663)  
Ending Balance (in Shares) at Jun. 30, 2024   5,750,000          
Beginning Balance at Apr. 03, 2024 $ 0 $ 0 0   0 0  
Beginning Balance (in Shares) at Apr. 03, 2024 0 0          
Net income           1,018,558  
Ending Balance at Sep. 30, 2024 $ 575   (10,002,746) (10,002,171)  
Ending Balance (in Shares) at Sep. 30, 2024   5,750,000          
Beginning Balance at Apr. 03, 2024 $ 0 $ 0 0   0 0  
Beginning Balance (in Shares) at Apr. 03, 2024 0 0          
Issuance of Class B ordinary shares to Sponsor   $ 575 24,425     25,000  
Number of shares issued   5,750,000          
Accretion for Class A ordinary shares to redemption amount     (7,348,508)   (13,715,174) (21,063,682)  
Fair value of Public Warrants at issuance     6,850,000     6,850,000  
Allocated value of transaction costs     (54,917)     (54,917)  
Net income         3,408,788 3,408,788  
Ending Balance at Dec. 31, 2024 $ 0 $ 575 0   (10,306,386) (10,305,811) $ (13,490,552)
Ending Balance (in Shares) at Dec. 31, 2024 0 5,750,000          
Beginning Balance at Jun. 30, 2024 $ 575 24,425   (52,663) (27,663)  
Beginning Balance (in Shares) at Jun. 30, 2024   5,750,000          
Accretion for Class A ordinary shares to redemption amount (7,348,508)   (11,021,304) (18,369,812)  
Sale of 6,850,000 Private Placement Warrants 6,850,000   6,850,000  
Fair value of Public Warrants at issuance 529,000 $ 379,638 529,000 379,638
Allocated value of transaction costs (54,917)   (54,917)  
Net income   1,071,221 1,071,221 (2,810,304)
Ending Balance at Sep. 30, 2024 $ 575   (10,002,746) (10,002,171)  
Ending Balance (in Shares) at Sep. 30, 2024   5,750,000          
Beginning Balance at Dec. 31, 2024 $ 0 $ 575 0   (10,306,386) (10,305,811) (13,490,552)
Beginning Balance (in Shares) at Dec. 31, 2024 0 5,750,000          
Fair value of Public Warrants at issuance       2,594,531     2,594,531
Accretion for Class A ordinary shares to redemption amount   (2,462,864) (2,462,864)  
Net income   689,999 689,999  
Ending Balance at Mar. 31, 2025 $ 575   (12,079,251) (12,078,676)  
Ending Balance (in Shares) at Mar. 31, 2025   5,750,000          
Beginning Balance at Dec. 31, 2024 $ 0 $ 575 0   (10,306,386) (10,305,811) (13,490,552)
Beginning Balance (in Shares) at Dec. 31, 2024 0 5,750,000          
Net income           3,218,865 (21,780,225)
Ending Balance at Sep. 30, 2025 $ 575   (14,536,908) (14,536,333) (6,359,095)
Ending Balance (in Shares) at Sep. 30, 2025   5,750,000          
Beginning Balance at Mar. 31, 2025 $ 575   (12,079,251) (12,078,676)  
Beginning Balance (in Shares) at Mar. 31, 2025   5,750,000          
Accretion for Class A ordinary shares to redemption amount   (2,477,726) (2,477,726)  
Net income   601,027 601,027  
Ending Balance at Jun. 30, 2025 $ 0 $ 575 0   (13,955,950) (13,955,375)  
Ending Balance (in Shares) at Jun. 30, 2025 0 5,750,000          
Issuance of Class B ordinary shares to Sponsor       $ 25,797,137     25,797,200
Accretion for Class A ordinary shares to redemption amount   (2,508,797) (2,508,797)  
Net income   1,927,839 1,927,839 (9,279,205)
Ending Balance at Sep. 30, 2025 $ 575   $ (14,536,908) $ (14,536,333) $ (6,359,095)
Ending Balance (in Shares) at Sep. 30, 2025   5,750,000          
[1] Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 6). On August 19, 2024, the Company consummated its IPO and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 750,000 shares of Class B ordinary shares were no longer subject to forfeiture.